Pancreatic cancer-associated thrombosis

T H C Tam¹, R N Lui^{2

3}

Affiliations

¹ Division of Haematology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong SAR, China.
² Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong SAR, China.
³ Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.

Free article

Editorial

T H C Tam et al. Hong Kong Med J. 2023 Oct.

Free article

. 2023 Oct;29(5):378-379.

doi: 10.12809/hkmj235151. Epub 2023 Oct 10.

T H C Tam¹, R N Lui^{2

3}

¹ Division of Haematology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong SAR, China.
² Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong SAR, China.
³ Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.

No abstract available

Conflict of interest statement

Both authors have declared no conflicts of interest.

Risks and impacts of thromboembolism in patients with pancreatic cancer.
Chan LL, Lam KY, Lam DCM, Lau YM, Li L, Ng KKC, Tang RSY, Chan SL. Chan LL, et al. Hong Kong Med J. 2023 Oct;29(5):396-403. doi: 10.12809/hkmj219788. Epub 2023 Oct 4. Hong Kong Med J. 2023. PMID: 37789507